Clincosm LogoSign in Get a demo

Myeloproliferative Disorders

Showing 51 - 59 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

JAK-STAT Signalling Pathway in Familial Myeloproliferative

Completed
  • Myeloproliferative Disorders
  • Blood samples and buccal swabs
  • Paris, France
    Department of Hematology, Hospital Saint Antoine
Mar 7, 2013

Acute Disease, MDS, Leukemia, Myeloid, Chronic Trial in Stanford (ablative allogeneic hematopoietic cell transplantation)

Completed
  • Acute Disease
  • +6 more
  • ablative allogeneic hematopoietic cell transplantation
  • Stanford, California
    Stanford University School of Medicine
Dec 13, 2012

Myeloproliferative Disorders, Kidney Cancer, Leukemia Trial in Atlanta (biological, drug, procedure)

Completed
Has Results
  • Myeloproliferative Disorders
  • +6 more
  • anti-thymocyte globulin
  • +6 more
  • Atlanta, Georgia
    Blood and Marrow Transplant Group of Georgia
Aug 29, 2012

Myeloma, Plasma-Cell, Lymphoma, Malignant, Myeloproliferative Disorders Trial in Ann Arbor (Reduced intensity conditioning with

Completed
  • Myeloma, Plasma-Cell
  • +4 more
  • Reduced intensity conditioning with allogeneic transplant
  • Ann Arbor, Michigan
    The University of Michigan
Aug 7, 2012

Myelofibrosis, Myeloproliferative Disorders, Polycythemia Vera Trial in Australia, United States (SB1518)

Completed
  • Myelofibrosis
  • +3 more
  • Scottsdale, Arizona
  • +5 more
Apr 19, 2012

Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Atlanta (biological, drug, procedure)

Terminated
Has Results
  • Myeloproliferative Disorders
  • +4 more
  • anti-thymocyte globulin
  • +5 more
  • Atlanta, Georgia
    Blood and Marrow Transplant Group of Georgia
Mar 19, 2012

Myeloproliferative Disorders, Myelofibrosis, Polycythemia Vera Trial in United States (XL019)

Terminated
  • Myeloproliferative Disorders
  • +3 more
  • San Francisco, California
  • +4 more
Apr 4, 2011

MDS, Myeloproliferative Disorders, Blood and Marrow Transplant (BMT) Trial in Stanford (nonmyeloablative allogeneic

Completed
  • Myelodysplastic Syndromes
  • +4 more
  • nonmyeloablative allogeneic hematopoietic cell transplant
  • Stanford, California
    Stanford University School of Medicine
Oct 13, 2010

Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL), Myeloproliferative Disorders Trial in Italy (STI571)

Unknown status
  • Hypereosinophilic Syndrome
  • +2 more
  • Bologna, Italy
  • +13 more
Sep 14, 2009